These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


140 related items for PubMed ID: 8838435

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Pharmacological reactivity of human epicardial coronary arteries: characterization of relaxation responses to endothelium-derived relaxing factor.
    Stork AP, Cocks TM.
    Br J Pharmacol; 1994 Dec; 113(4):1099-104. PubMed ID: 7889260
    [Abstract] [Full Text] [Related]

  • 43. Direct vasodilator effect of milrinone, an inotropic drug, on arterial coronary bypass grafts. FANZCA .
    Liu JJ, Doolan LA, Xie B, Chen JR, Buxton BF.
    J Thorac Cardiovasc Surg; 1997 Jan; 113(1):108-13. PubMed ID: 9011679
    [Abstract] [Full Text] [Related]

  • 44. Novel angiotensin II AT(1) receptor antagonist irbesartan prevents thromboxane A(2)-induced vasoconstriction in canine coronary arteries and human platelet aggregation.
    Li P, Fukuhara M, Diz DI, Ferrario CM, Brosnihan KB.
    J Pharmacol Exp Ther; 2000 Jan; 292(1):238-46. PubMed ID: 10604953
    [Abstract] [Full Text] [Related]

  • 45. Thromboxane A2-mediated shape change: independent of Gq-phospholipase C--Ca2+ pathway in rabbit platelets.
    Ohkubo S, Nakahata N, Ohizumi Y.
    Br J Pharmacol; 1996 Mar; 117(6):1095-104. PubMed ID: 8882602
    [Abstract] [Full Text] [Related]

  • 46. The thromboxane A2 and K(ATP) channel antagonist actions of a series of sulphonylurea derivatives in the pig coronary artery.
    McPherson GA, Choi RT, Kong DC, Iskander MN.
    Eur J Pharmacol; 1997 Apr 18; 324(2-3):193-200. PubMed ID: 9145771
    [Abstract] [Full Text] [Related]

  • 47. Benextramine acts as an irreversible noncompetitive antagonist of U46619-mediated contraction of the rat small mesenteric artery.
    Van der Graaf PH, Stam WB, Saxena PR.
    Eur J Pharmacol; 1996 Apr 11; 300(3):211-4. PubMed ID: 8739210
    [Abstract] [Full Text] [Related]

  • 48. Coronary artery constriction by the isoprostane 8-epi prostaglandin F2 alpha.
    Kromer BM, Tippins JR.
    Br J Pharmacol; 1996 Nov 11; 119(6):1276-80. PubMed ID: 8937734
    [Abstract] [Full Text] [Related]

  • 49. Variable potency of nitrergic-nitrovasodilator relaxations of the mouse anococcygeus against different forms of induced tone.
    Gibson A, McFadzean I, Tucker JF, Wayman C.
    Br J Pharmacol; 1994 Dec 11; 113(4):1494-500. PubMed ID: 7889307
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Spasmolytic effect of efonidipine hydrochloride in isolated canine coronary artery: comparison with the effects of nifedipine and nisoldipine.
    Jin H, Sato R, Higashino R, Fukuda Y, Kurimoto T, Tamaki H.
    Biol Pharm Bull; 1997 Feb 11; 20(2):196-200. PubMed ID: 9057986
    [Abstract] [Full Text] [Related]

  • 52. Mechanism of ITF 296-induced vasorelaxation compared to nitroglycerin and isosorbide dinitrate: relationship between relaxation of rabbit aorta and tissue cGMP.
    Donà G, Giuliani P, Cremonesi P, Passaro A, Stella P, Tursi F, Mizrahi J.
    J Cardiovasc Pharmacol; 1995 Feb 11; 26 Suppl 4():S59-66. PubMed ID: 8839228
    [Abstract] [Full Text] [Related]

  • 53. Endothelium-dependent relaxation by substance P in human isolated omental arteries and veins: relative contribution of prostanoids, nitric oxide and hyperpolarization.
    Wallerstedt SM, Bodelsson M.
    Br J Pharmacol; 1997 Jan 11; 120(1):25-30. PubMed ID: 9117094
    [Abstract] [Full Text] [Related]

  • 54. Inhibition of human internal mammary artery contractions. An in vitro study of vasodilators.
    Jett GK, Guyton RA, Hatcher CR, Abel PW.
    J Thorac Cardiovasc Surg; 1992 Oct 11; 104(4):977-82. PubMed ID: 1405699
    [Abstract] [Full Text] [Related]

  • 55. Pharmacological reactivity of human epicardial coronary arteries: phasic and tonic responses to vasoconstrictor agents differentiated by nifedipine.
    Stork AP, Cocks TM.
    Br J Pharmacol; 1994 Dec 11; 113(4):1093-8. PubMed ID: 7889259
    [Abstract] [Full Text] [Related]

  • 56. Phenol red is a thromboxane A2/prostaglandin H2 receptor antagonist in canine lingual arteries and human platelets.
    Greenberg SS, Johns A, Kleha J, Xie J, Wang Y, Bianchi J, Conley K.
    J Pharmacol Exp Ther; 1994 Mar 11; 268(3):1352-61. PubMed ID: 8138950
    [Abstract] [Full Text] [Related]

  • 57. Estrogen pretreatment directly potentiates endothelium-dependent vasorelaxation of porcine coronary arteries.
    Bell DR, Rensberger HJ, Koritnik DR, Koshy A.
    Am J Physiol; 1995 Jan 11; 268(1 Pt 2):H377-83. PubMed ID: 7840287
    [Abstract] [Full Text] [Related]

  • 58. Lack of endotoxin-induced hyporesponsiveness to U46619 in isolated neonatal porcine pulmonary but not mesenteric arteries.
    Pérez-Vizcaíno F, Villamor E, Fernandez del Pozo B, Moro M, Tamargo J.
    J Vasc Res; 1996 Jan 11; 33(3):249-57. PubMed ID: 8924522
    [Abstract] [Full Text] [Related]

  • 59. Inhibition of vasoconstriction by the thromboxane A2 antagonist GR32191B in the human radial artery.
    He GW, Yang CQ.
    Br J Clin Pharmacol; 1999 Aug 11; 48(2):207-15. PubMed ID: 10417498
    [Abstract] [Full Text] [Related]

  • 60. Effects of potassium channel opener aprikalim on the receptor-mediated vasoconstriction in the human internal mammary artery.
    Liu MH, Floten HS, Furnary AP, Yim AP, He GW.
    Ann Thorac Surg; 2001 Feb 11; 71(2):636-41. PubMed ID: 11235720
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.